August 29, 2016 3:16 PM ET

Life Sciences Tools and Services

Company Overview of Leap Therapeutics, Inc.

Executive Profile

Christopher K. Mirabelli Ph.D.

Chief Executive Officer, President, and Director, Leap Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 18 different industries.

See Board Relationships
62--

Background

Dr. Christopher K. Mirabelli, also known as Chris, Ph.D., serves as the President of DecImmune Therapeutics, Inc. Dr. Mirabelli is a Managing Partner at HealthCare Ventures LLC and has been its Managing Director since 2000. He serves as Managing Partner and Managing Director at HealthCare Ventures VII, L.P. and HealthCare Ventures VIII, L.P. Dr. Mirabelli serves as the President at Anexon, Inc. He serves as President and Director of Apofore Corp. He served as Chief Executive ...

Corporate Headquarters

55 Cambridge Parkway
Cambridge, Massachusetts 02142

United States

Phone: 617-252-4343
Fax: 617-252-4342

Board Members Memberships

Director
Director
President and Director
Chief Executive Officer, President, and Director
President and Director
Director

Education

PhD
Baylor College of Medicine
BS
SUNY-Fredonia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Leap Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.